DeepTek CXR Analyzer vs KardiaAI
AI Verdict
Choose DeepTek CXR Analyzer if…
Choose DeepTek CXR Analyzer if your radiology department processes a high volume of chest X-rays and seeks to significantly improve diagnostic accuracy and workflow efficiency. This AI-powered CADe solution is ideal for automatically detecting and highlighting a broad spectrum of lung, pleural, and cardiac pathologies, thereby reducing radiologist workload and streamlining the interpretation process.
View DeepTek CXR Analyzer →Choose KardiaAI if…
Choose KardiaAI if you require an FDA-cleared AI software library for integrating advanced, medical-grade ECG rhythm analysis into mobile applications, web platforms, or other ambulatory ECG devices. This tool is specifically designed for the accurate detection of various cardiac rhythm conditions, such as AFib, bradycardia, and tachycardia, for continuous or on-demand heart rhythm monitoring.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | DeepTek CXR Analyzer | KardiaAI |
|---|---|---|
| Pricing | Global access pricing available for eligible public sector and not-for-profit healthcare providers in 138 low- and middle-income countries, offering unlimited ai analyses per connected x-ray unit, installation, user training, product updates, maintenance, and technical support via an annual subscription. | Subscription-based for advanced features and services. |
| Deployment | On-premise and Cloud offerings. The solution supports online, offline, and hybrid deployment. | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
DeepTek CXR AnalyzerDeepTek CXR Analyzer is designed for seamless DICOM-based PACS integration, allowing radiologists to incorporate it directly into their existing workflow for immediate use. Its output is generated as secondary capture DICOM, making interpretation straightforward within the familiar clinical environment. This direct integration and workflow enhancement make it highly usable for its target clinical users.
Clinical Value
DeepTek CXR AnalyzerBoth tools are FDA-cleared and offer significant clinical value in their respective domains. DeepTek CXR Analyzer detects 28 findings across lung, pleural, and cardiac pathologies, directly assisting radiologists in improving diagnostic accuracy and significantly reducing workload by 30-50% and boosting productivity by 2x-3x. This broad diagnostic coverage and quantifiable impact on workflow efficiency give it a slight edge in overall clinical operational value.
Pricing & Value
KardiaAIKardiaAI offers transparent, subscription-based pricing for its integrated services, with clear monthly and annual options. This provides potential users with predictable costs and a straightforward understanding of the financial commitment. DeepTek CXR Analyzer, while offering a flexible pay-per-use model, requires contacting sales for pricing, which lacks initial transparency.
Enterprise Readiness
DeepTek CXR AnalyzerBoth tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong foundational enterprise readiness. DeepTek CXR Analyzer offers both cloud and on-premise deployment options and seamless DICOM-based PACS integration, which are critical for direct integration into existing hospital and radiology enterprise infrastructures. While KardiaAI's API library offers flexibility, Tool A's direct workflow integration capabilities make it more immediately 'ready' for typical enterprise clinical deployments.
Innovation
KardiaAIWhile DeepTek CXR Analyzer provides robust AI-powered CADe for chest X-rays with a broad range of findings, KardiaAI's approach as an FDA-cleared AI software library for ambulatory ECG analysis is highly innovative. Its API library model allows for integration into various other ECG devices and software, enabling a wider and more flexible application of medical-grade AI for heart rhythm data across different platforms and settings.
Support & Docs
KardiaAIThe provided structured facts do not detail support or documentation for either tool. However, as an API library, KardiaAI inherently requires comprehensive developer documentation and robust support channels for successful integration by third parties. AliveCor, as an established company with consumer and professional products, is expected to have well-developed support resources and documentation for its integrators.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | DeepTek CXR Analyzer | KardiaAI |
|---|---|---|
| Name | DeepTek CXR Analyzer | KardiaAI |
| Company | DeepTek Medical Imaging Pvt | AliveCor |
| Description | FDA-cleared AI-powered CADe solution for chest X-ray analysis, designed to assist radiologists by automatically detecting and highlighting suspicious regions across lung, pleural, and cardiac pathologies. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Primary Analysis Target | Chest X-rays | Ambulatory ECG rhythms |
| Key Detections/Findings | Detection of 28 findings covering lung, pleural, cardiac pathologies, and hardware; automatic identification, categorization, and highlighting of suspicious regions of interest (ROIs). | Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE). |
Videos
Demos, reviews, and walkthroughs featuring DeepTek CXR Analyzer and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring DeepTek CXR Analyzer or KardiaAI
Backers
Who funded each tool's parent company.